Recent searches

No recent searches

Search options

Only available when logged in.
mstdn.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
A general-purpose Mastodon server with a 500 character limit. All languages are welcome.

Administered by:

Server stats:

12K
active users

mstdn.social: AboutStatusProfiles directoryPrivacy policyTerms of service

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.4.1

ombra

The subtext I am reading here is:
because neither pharmaceuticals nor health professionals can earn a lot of money with , it will not happen quickly with approvals.
Why should these help so that many people can live without or the like, or that many years of therapy are not necessary?

And: our consumer world does not need more satisfied people either, the would say...

theguardian.com/science/2023/a

The GuardianIs the therapeutic potential of hallucinogens risky and overhyped?By David Cox
#psylocybin#PsychotherapyResearch
··Tusky
1boost·1favorite
ombra

Study "Using a - and -Group Therapy Model in Clinical Practice in Switzerland .."(Oehen, . 2022)
frontiersin.org/articles/10.33
"In our exp., group experiences intensified and deepened the individual therapeutic process and made it therapeutically more efficient in regard to outcomes than in an individual setting. The group setting also allowed to treat more patients in the given time.
There were no safety problems and no serious adverse events requiring hospitalization.1/2

FrontiersUsing a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related DisordersThe Swiss Federal Act on Narcotics allows for the restricted medical use of scheduled psychotropic drugs in cases of resistance to standard treatment, and preliminary evidence of efficacy of the scheduled drug for the particular condition. Since 2014, the authors have obtained 50 licenses on a case-by-case basis and developed a psychedelic-assisted group therapy model utilizing MDMA and LSD. The majority of the patients taking part in the psychedelic group therapy suffered from chronic complex post-traumatic stress disorder (c-PTSD), dissociative, and other post-traumatic disorders. Treatment modalities, typical developments and problems encountered during and after the psychedelic experiences are described. Recurrent depression poses a frequent problem, and requires special attention. Symptoms of c-PTSD predominantly addressed by the psychedelic experiences are the regulation of emotions and impulses, negative self-perception, alterations in relationships to others, as well as meaning, recall, and processing of traumatic memories. C-PTSD needs a larger number of psychedelic experiences in contrast to PTSD resulting from single trauma. In this model MDMA was most often used in the first phase to enhance motivation to change, strengthen the therapeutic alliance, allowing it to become more resilient, stress-relieved and less ambivalent. When emotional self-regulation, negative self-perception and structural dissociation had also begun to improve and trauma exposure was bette...
ombra

...The group therapy model presented here suggests the feasibility and safety of this approach.
Given the current high need for more effective treatments for chronic trauma-related disorders, OCD, chronic depression and anxiety disorders, the “restricted medical use program” is an invaluable way to help otherwise treatment-resistant patients until these psychedelics have become registered drugs." 2/2

TrendingLive feeds
About